Certara, Inc. (NASDAQ:CERT) Insider Sells $606,000.00 in Stock

Certara, Inc. (NASDAQ:CERT) insider Jieun W. Choe sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, November 19th. The stock was sold at an average price of $30.30, for a total value of $606,000.00. The sale was disclosed in a filing with the SEC, which is available through this link.

Shares of NASDAQ:CERT opened at $28.50 on Thursday. Certara, Inc. has a 12-month low of $23.75 and a 12-month high of $45.48. The business’s fifty day simple moving average is $36.78 and its 200-day simple moving average is $31.24. The company has a market capitalization of $4.55 billion and a PE ratio of -67.86. The company has a current ratio of 7.25, a quick ratio of 7.25 and a debt-to-equity ratio of 0.30.

Certara (NASDAQ:CERT) last announced its quarterly earnings results on Monday, November 8th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.06 by $0.01. Certara had a negative return on equity of 2.85% and a negative net margin of 21.07%. The business had revenue of $73.94 million for the quarter, compared to the consensus estimate of $73.90 million. Research analysts predict that Certara, Inc. will post 0.1 EPS for the current year.

Several research firms have commented on CERT. Zacks Investment Research upgraded Certara from a “sell” rating to a “hold” rating in a report on Monday, November 15th. Robert W. Baird raised their price objective on Certara from $32.00 to $41.00 and gave the stock an “outperform” rating in a report on Friday, September 17th. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $36.33.

Several large investors have recently made changes to their positions in the company. American International Group Inc. boosted its position in shares of Certara by 127.3% in the 3rd quarter. American International Group Inc. now owns 1,325 shares of the company’s stock worth $44,000 after purchasing an additional 742 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Certara by 138.2% in the 3rd quarter. Bank of New York Mellon Corp now owns 285,819 shares of the company’s stock worth $9,462,000 after purchasing an additional 165,844 shares in the last quarter. Captrust Financial Advisors boosted its position in shares of Certara by 48.7% in the 3rd quarter. Captrust Financial Advisors now owns 904 shares of the company’s stock worth $30,000 after purchasing an additional 296 shares in the last quarter. Janus Henderson Group PLC acquired a new stake in shares of Certara in the 3rd quarter worth $676,000. Finally, Jane Street Group LLC boosted its position in shares of Certara by 886.1% in the 3rd quarter. Jane Street Group LLC now owns 97,795 shares of the company’s stock worth $3,237,000 after purchasing an additional 87,878 shares in the last quarter. Institutional investors and hedge funds own 48.87% of the company’s stock.

About Certara

Certara Inc provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development.

Featured Story: Certificate of Deposit (CD)

Insider Buying and Selling by Quarter for Certara (NASDAQ:CERT)

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.